The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Dyslipidemia is especially relevant in vulnerable populations such as postmenopausal women.

Due to contradictory findings from intervention trials, the researchers investigated the effect of vitamin D supplementation on serum lipids in postmenopausal women with type 2 diabetes.

Who Took Part

The abstract describes 104 women taking part.

PubMed indexes the participants as middle-aged adults and older adults, women only.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

What Was Measured

PubMed files the paper under topics including Body Mass Index, C-Reactive Protein, Cholesterol, HDL, Cholesterol, LDL, Diabetes Mellitus, Type 2, Dietary Supplements and Nutrition Assessment.

The authors tagged it with the keywords Postmenopausal women, Serum lipids and Vitamin D supplementation.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 104 women.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2015 (Clinical nutrition (Edinburgh, Scotland)), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.